May Measurement Month 2017: an analysis of blood pressure screening results from Australia-South-East Asia and Australasia

Revathy Carnagarin, Ricardo Fonseca, Derrin Brockman, Dagmara Hering, Vance Matthews, Anastasia Mihailidou, Christopher Reid, Rebecca Lee, Gavin W. Lambert, Louise M. Burrell, James E. Sharman, Xin Xia, Neil R. Poulter, Thomas Beaney, Sheikh Mohammed Shariful Islam, Melinda Carrington, Markus Schlaich

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Increased blood pressure (BP) is the single biggest contributing risk factor to the global disease burden. May Measurement Month (MMM) is a global initiative of the International Society of Hypertension aimed at raising awareness of high BP. In Australia, hypertension affects around six million adults and continues to remain the greatest attributable cause of cardiovascular mortality and morbidity (48.3%), stroke deaths (28%), and kidney disease (14%). An opportunistic cross-sectional survey was carried out during May 2017 predominantly in capital cities across Australia which included adult volunteers. Blood pressure measurement, the definition of hypertension and statistical analysis followed the standard MMM protocol. Additional information obtained included anthropometric data and responses to questionnaires on demographic, lifestyle, and environmental factors. Data were collected from 3817 individuals. After multiple imputation, of the 3758 individuals for whom a mean of the second and third BP reading was available, 1188 (31.2%) had hypertension. Of 3213 individuals not receiving antihypertensive treatment, 591 (18.4%) were hypertensive, and 239 (40.1%) of the 596 individuals receiving treatment had uncontrolled BP. Adjusted BP was higher in association with antihypertensive medication, cerebrovascular disease, smoking, and alcohol consumption. Blood pressure was higher when measured on the right arm and on Tuesdays. MMM17 was one of the largest BP screening campaigns undertaken in Australia using standardized BP measurements. In line with previous surveys, around one-third of screened adults had hypertension and approximately 40% of treated individuals remained uncontrolled. These results suggest that opportunistic screening can identify significant numbers with raised BP.
Original languageEnglish
Pages (from-to)D14-D16
JournalEuropean Heart Journal Supplements
Volume21
Issue numberSuppl. D
DOIs
Publication statusPublished - 24 Apr 2019

Fingerprint

Australasia
South Australia
Far East
Blood Pressure
Hypertension
Antihypertensive Agents
Cerebrovascular Disorders
Kidney Diseases
Alcohol Drinking
Life Style
Reading
Volunteers
Cross-Sectional Studies
Smoking
Stroke
Demography
Morbidity
Mortality
Therapeutics

Cite this

Carnagarin, Revathy ; Fonseca, Ricardo ; Brockman, Derrin ; Hering, Dagmara ; Matthews, Vance ; Mihailidou, Anastasia ; Reid, Christopher ; Lee, Rebecca ; Lambert, Gavin W. ; Burrell, Louise M. ; Sharman, James E. ; Xia, Xin ; Poulter, Neil R. ; Beaney, Thomas ; Islam, Sheikh Mohammed Shariful ; Carrington, Melinda ; Schlaich, Markus. / May Measurement Month 2017 : an analysis of blood pressure screening results from Australia-South-East Asia and Australasia. In: European Heart Journal Supplements. 2019 ; Vol. 21, No. Suppl. D. pp. D14-D16.
@article{953cd363001c45a4bfcb15e4bcbdb27e,
title = "May Measurement Month 2017: an analysis of blood pressure screening results from Australia-South-East Asia and Australasia",
abstract = "Increased blood pressure (BP) is the single biggest contributing risk factor to the global disease burden. May Measurement Month (MMM) is a global initiative of the International Society of Hypertension aimed at raising awareness of high BP. In Australia, hypertension affects around six million adults and continues to remain the greatest attributable cause of cardiovascular mortality and morbidity (48.3{\%}), stroke deaths (28{\%}), and kidney disease (14{\%}). An opportunistic cross-sectional survey was carried out during May 2017 predominantly in capital cities across Australia which included adult volunteers. Blood pressure measurement, the definition of hypertension and statistical analysis followed the standard MMM protocol. Additional information obtained included anthropometric data and responses to questionnaires on demographic, lifestyle, and environmental factors. Data were collected from 3817 individuals. After multiple imputation, of the 3758 individuals for whom a mean of the second and third BP reading was available, 1188 (31.2{\%}) had hypertension. Of 3213 individuals not receiving antihypertensive treatment, 591 (18.4{\%}) were hypertensive, and 239 (40.1{\%}) of the 596 individuals receiving treatment had uncontrolled BP. Adjusted BP was higher in association with antihypertensive medication, cerebrovascular disease, smoking, and alcohol consumption. Blood pressure was higher when measured on the right arm and on Tuesdays. MMM17 was one of the largest BP screening campaigns undertaken in Australia using standardized BP measurements. In line with previous surveys, around one-third of screened adults had hypertension and approximately 40{\%} of treated individuals remained uncontrolled. These results suggest that opportunistic screening can identify significant numbers with raised BP.",
author = "Revathy Carnagarin and Ricardo Fonseca and Derrin Brockman and Dagmara Hering and Vance Matthews and Anastasia Mihailidou and Christopher Reid and Rebecca Lee and Lambert, {Gavin W.} and Burrell, {Louise M.} and Sharman, {James E.} and Xin Xia and Poulter, {Neil R.} and Thomas Beaney and Islam, {Sheikh Mohammed Shariful} and Melinda Carrington and Markus Schlaich",
year = "2019",
month = "4",
day = "24",
doi = "10.1093/eurheartj/suz052",
language = "English",
volume = "21",
pages = "D14--D16",
journal = "European Heart Journal Supplements",
issn = "1520-765X",
publisher = "Oxford University Press",
number = "Suppl. D",

}

Carnagarin, R, Fonseca, R, Brockman, D, Hering, D, Matthews, V, Mihailidou, A, Reid, C, Lee, R, Lambert, GW, Burrell, LM, Sharman, JE, Xia, X, Poulter, NR, Beaney, T, Islam, SMS, Carrington, M & Schlaich, M 2019, 'May Measurement Month 2017: an analysis of blood pressure screening results from Australia-South-East Asia and Australasia' European Heart Journal Supplements, vol. 21, no. Suppl. D, pp. D14-D16. https://doi.org/10.1093/eurheartj/suz052

May Measurement Month 2017 : an analysis of blood pressure screening results from Australia-South-East Asia and Australasia. / Carnagarin, Revathy; Fonseca, Ricardo; Brockman, Derrin; Hering, Dagmara; Matthews, Vance; Mihailidou, Anastasia; Reid, Christopher; Lee, Rebecca; Lambert, Gavin W.; Burrell, Louise M.; Sharman, James E.; Xia, Xin; Poulter, Neil R.; Beaney, Thomas; Islam, Sheikh Mohammed Shariful; Carrington, Melinda; Schlaich, Markus.

In: European Heart Journal Supplements, Vol. 21, No. Suppl. D, 24.04.2019, p. D14-D16.

Research output: Contribution to journalArticle

TY - JOUR

T1 - May Measurement Month 2017

T2 - an analysis of blood pressure screening results from Australia-South-East Asia and Australasia

AU - Carnagarin, Revathy

AU - Fonseca, Ricardo

AU - Brockman, Derrin

AU - Hering, Dagmara

AU - Matthews, Vance

AU - Mihailidou, Anastasia

AU - Reid, Christopher

AU - Lee, Rebecca

AU - Lambert, Gavin W.

AU - Burrell, Louise M.

AU - Sharman, James E.

AU - Xia, Xin

AU - Poulter, Neil R.

AU - Beaney, Thomas

AU - Islam, Sheikh Mohammed Shariful

AU - Carrington, Melinda

AU - Schlaich, Markus

PY - 2019/4/24

Y1 - 2019/4/24

N2 - Increased blood pressure (BP) is the single biggest contributing risk factor to the global disease burden. May Measurement Month (MMM) is a global initiative of the International Society of Hypertension aimed at raising awareness of high BP. In Australia, hypertension affects around six million adults and continues to remain the greatest attributable cause of cardiovascular mortality and morbidity (48.3%), stroke deaths (28%), and kidney disease (14%). An opportunistic cross-sectional survey was carried out during May 2017 predominantly in capital cities across Australia which included adult volunteers. Blood pressure measurement, the definition of hypertension and statistical analysis followed the standard MMM protocol. Additional information obtained included anthropometric data and responses to questionnaires on demographic, lifestyle, and environmental factors. Data were collected from 3817 individuals. After multiple imputation, of the 3758 individuals for whom a mean of the second and third BP reading was available, 1188 (31.2%) had hypertension. Of 3213 individuals not receiving antihypertensive treatment, 591 (18.4%) were hypertensive, and 239 (40.1%) of the 596 individuals receiving treatment had uncontrolled BP. Adjusted BP was higher in association with antihypertensive medication, cerebrovascular disease, smoking, and alcohol consumption. Blood pressure was higher when measured on the right arm and on Tuesdays. MMM17 was one of the largest BP screening campaigns undertaken in Australia using standardized BP measurements. In line with previous surveys, around one-third of screened adults had hypertension and approximately 40% of treated individuals remained uncontrolled. These results suggest that opportunistic screening can identify significant numbers with raised BP.

AB - Increased blood pressure (BP) is the single biggest contributing risk factor to the global disease burden. May Measurement Month (MMM) is a global initiative of the International Society of Hypertension aimed at raising awareness of high BP. In Australia, hypertension affects around six million adults and continues to remain the greatest attributable cause of cardiovascular mortality and morbidity (48.3%), stroke deaths (28%), and kidney disease (14%). An opportunistic cross-sectional survey was carried out during May 2017 predominantly in capital cities across Australia which included adult volunteers. Blood pressure measurement, the definition of hypertension and statistical analysis followed the standard MMM protocol. Additional information obtained included anthropometric data and responses to questionnaires on demographic, lifestyle, and environmental factors. Data were collected from 3817 individuals. After multiple imputation, of the 3758 individuals for whom a mean of the second and third BP reading was available, 1188 (31.2%) had hypertension. Of 3213 individuals not receiving antihypertensive treatment, 591 (18.4%) were hypertensive, and 239 (40.1%) of the 596 individuals receiving treatment had uncontrolled BP. Adjusted BP was higher in association with antihypertensive medication, cerebrovascular disease, smoking, and alcohol consumption. Blood pressure was higher when measured on the right arm and on Tuesdays. MMM17 was one of the largest BP screening campaigns undertaken in Australia using standardized BP measurements. In line with previous surveys, around one-third of screened adults had hypertension and approximately 40% of treated individuals remained uncontrolled. These results suggest that opportunistic screening can identify significant numbers with raised BP.

U2 - 10.1093/eurheartj/suz052

DO - 10.1093/eurheartj/suz052

M3 - Article

VL - 21

SP - D14-D16

JO - European Heart Journal Supplements

JF - European Heart Journal Supplements

SN - 1520-765X

IS - Suppl. D

ER -